News

Asston Pharmaceuticals shares make weak debut, lists at ₹119, down 3.25% from IPO price
Asston Pharmaceuticals debuted at ₹119 on BSE SME on July 16, down 3.25% from its IPO price of ₹123. The IPO raised ₹27.63 ...
Capital Market on MSN24m
Barometers end near flat line; Nifty closes above 25,200 mark
The key benchmark indices ended with small gains today, witnessing mild buying interest despite Donald Trump announced a 19% tariff on products that Indonesia sells to the United States. Further Trump ...
Fierce Biotech33m
Personalized spine surgery developer Carlsmed plots $100M+ IPO
The artificial intelligence-powered spine surgery developer Carlsmed is showing some backbone as it kicks off its IPO, with ...